Quick Answer
KAZIA THERAPEUTICS LTD reported Total Assets of $6.06 million for fiscal year 2025.
KAZIA THERAPEUTICS LTD — Key Financials by Year
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Total Assets | $6.06M -71.9% |
$21.59M -23.1% |
$28.08M -21.7% |
$35.89M -37.1% |
$57.09M +147.6% |
$23.06M +8.9% |
| R&D Expense | $7.33M -57.8% |
$17.38M +11.7% |
$15.56M -22.8% |
$20.17M +38.7% |
$14.54M +53.2% |
$9.49M +46.6% |
- KAZIA THERAPEUTICS LTD reported Total Assets of $6.06 million for fiscal year 2025.
- KAZIA THERAPEUTICS LTD showed a decrease of -71.9% in Total Assets compared to the prior fiscal year.
- KAZIA THERAPEUTICS LTD reported R&D Expense of $7.33 million for fiscal year 2025.
- KAZIA THERAPEUTICS LTD showed a decrease of -57.8% in R&D Expense compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: